Cargando…

Frequency of Her2/neu expression in colorectal adenocarcinoma: a study from developing South Asian Country

BACKGROUND: Human Epidermal Growth Factor (Her-2/neu) has strong therapeutic implications in certain cancers like breast and gastric cancer. Literature on its frequency in colorectal cancer is scarce. In this study, we have investigated the frequency of Her-2/neu expression in colorectal adenocarcin...

Descripción completa

Detalles Bibliográficos
Autores principales: Shabbir, Asma, Mirza, Talat, Khalid, Abdullah Bin, Qureshi, Muhammad Asif, Asim, Sadaf Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100101/
https://www.ncbi.nlm.nih.gov/pubmed/27821098
http://dx.doi.org/10.1186/s12885-016-2912-y
_version_ 1782466069034696704
author Shabbir, Asma
Mirza, Talat
Khalid, Abdullah Bin
Qureshi, Muhammad Asif
Asim, Sadaf Ahmed
author_facet Shabbir, Asma
Mirza, Talat
Khalid, Abdullah Bin
Qureshi, Muhammad Asif
Asim, Sadaf Ahmed
author_sort Shabbir, Asma
collection PubMed
description BACKGROUND: Human Epidermal Growth Factor (Her-2/neu) has strong therapeutic implications in certain cancers like breast and gastric cancer. Literature on its frequency in colorectal cancer is scarce. In this study, we have investigated the frequency of Her-2/neu expression in colorectal adenocarcinomas and its association with various clinicopathological variables. METHODS: A total of 95 patients who underwent colonoscopic biopsy or colectomy were studied after Institutional Ethical Approval. Hematoxylin & eosin (H&E) staining was performed on all the tissue sections. Expression of Her-2/neu was investigated by immunohistochemistry using α-Her-2 antibody. In order to quantify Her-2/neu expression, three criterias were applied that includes the pattern of staining, intensity of staining and percentage of tumor cells stained. Furthermore, its association was seen with various clinicopathological variables including age, gender, histopathological type, grade and stage of the tumor. Data was entered and analyzed using SPSS version 21. A p-value of < 0.05 was considered as significant. RESULTS: From the total of 95 cases, 75 (78.9 %) cases showed Her-2/neu expression. Pattern of Her-2/neu staining was significantly associated with the grade of colorectal cancer depicting cytoplasmic Her-2/neu expression higher in low grade (50 %) while membranous Her-2/neu expression more in high grade colorectal cancer (45 %) (P-value = 0.030). Pattern of Her-2/neu staining was also significantly associated with the type of colorectal cancer representing membranous Her-2/neu expression to be more common in mucinous type (38.5 %) while cytoplasmic Her-2/neu expression to be more frequent in non mucinous type (42.7 %) of colorectal cancer (p-value = 0.024). We observed a significant association between percentage of cells stained & tumor type, with score 3+ maximum in non mucinous type of colorectal cancer (p-value = 0.006). CONCLUSION: Her2/neu is considerably expressed in colorectal adenocarcinoma in Pakistani population. Our findings indicate a significant strong association of cytoplasmic Her-2/neu expression with low grades and membranous Her-2/neu expression with high grades of colorectal cancer. These findings add to the body of information & may help in conducting clinical trials in future to explore its therapeutic significance as well.
format Online
Article
Text
id pubmed-5100101
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-51001012016-11-08 Frequency of Her2/neu expression in colorectal adenocarcinoma: a study from developing South Asian Country Shabbir, Asma Mirza, Talat Khalid, Abdullah Bin Qureshi, Muhammad Asif Asim, Sadaf Ahmed BMC Cancer Research Article BACKGROUND: Human Epidermal Growth Factor (Her-2/neu) has strong therapeutic implications in certain cancers like breast and gastric cancer. Literature on its frequency in colorectal cancer is scarce. In this study, we have investigated the frequency of Her-2/neu expression in colorectal adenocarcinomas and its association with various clinicopathological variables. METHODS: A total of 95 patients who underwent colonoscopic biopsy or colectomy were studied after Institutional Ethical Approval. Hematoxylin & eosin (H&E) staining was performed on all the tissue sections. Expression of Her-2/neu was investigated by immunohistochemistry using α-Her-2 antibody. In order to quantify Her-2/neu expression, three criterias were applied that includes the pattern of staining, intensity of staining and percentage of tumor cells stained. Furthermore, its association was seen with various clinicopathological variables including age, gender, histopathological type, grade and stage of the tumor. Data was entered and analyzed using SPSS version 21. A p-value of < 0.05 was considered as significant. RESULTS: From the total of 95 cases, 75 (78.9 %) cases showed Her-2/neu expression. Pattern of Her-2/neu staining was significantly associated with the grade of colorectal cancer depicting cytoplasmic Her-2/neu expression higher in low grade (50 %) while membranous Her-2/neu expression more in high grade colorectal cancer (45 %) (P-value = 0.030). Pattern of Her-2/neu staining was also significantly associated with the type of colorectal cancer representing membranous Her-2/neu expression to be more common in mucinous type (38.5 %) while cytoplasmic Her-2/neu expression to be more frequent in non mucinous type (42.7 %) of colorectal cancer (p-value = 0.024). We observed a significant association between percentage of cells stained & tumor type, with score 3+ maximum in non mucinous type of colorectal cancer (p-value = 0.006). CONCLUSION: Her2/neu is considerably expressed in colorectal adenocarcinoma in Pakistani population. Our findings indicate a significant strong association of cytoplasmic Her-2/neu expression with low grades and membranous Her-2/neu expression with high grades of colorectal cancer. These findings add to the body of information & may help in conducting clinical trials in future to explore its therapeutic significance as well. BioMed Central 2016-11-07 /pmc/articles/PMC5100101/ /pubmed/27821098 http://dx.doi.org/10.1186/s12885-016-2912-y Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Shabbir, Asma
Mirza, Talat
Khalid, Abdullah Bin
Qureshi, Muhammad Asif
Asim, Sadaf Ahmed
Frequency of Her2/neu expression in colorectal adenocarcinoma: a study from developing South Asian Country
title Frequency of Her2/neu expression in colorectal adenocarcinoma: a study from developing South Asian Country
title_full Frequency of Her2/neu expression in colorectal adenocarcinoma: a study from developing South Asian Country
title_fullStr Frequency of Her2/neu expression in colorectal adenocarcinoma: a study from developing South Asian Country
title_full_unstemmed Frequency of Her2/neu expression in colorectal adenocarcinoma: a study from developing South Asian Country
title_short Frequency of Her2/neu expression in colorectal adenocarcinoma: a study from developing South Asian Country
title_sort frequency of her2/neu expression in colorectal adenocarcinoma: a study from developing south asian country
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100101/
https://www.ncbi.nlm.nih.gov/pubmed/27821098
http://dx.doi.org/10.1186/s12885-016-2912-y
work_keys_str_mv AT shabbirasma frequencyofher2neuexpressionincolorectaladenocarcinomaastudyfromdevelopingsouthasiancountry
AT mirzatalat frequencyofher2neuexpressionincolorectaladenocarcinomaastudyfromdevelopingsouthasiancountry
AT khalidabdullahbin frequencyofher2neuexpressionincolorectaladenocarcinomaastudyfromdevelopingsouthasiancountry
AT qureshimuhammadasif frequencyofher2neuexpressionincolorectaladenocarcinomaastudyfromdevelopingsouthasiancountry
AT asimsadafahmed frequencyofher2neuexpressionincolorectaladenocarcinomaastudyfromdevelopingsouthasiancountry